Sage Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $588k | 31k | 18.75 |
| 2023-12-31 | $721k | 33k | 21.67 |
| 2023-09-30 | $722k | 35k | 20.59 |
| 2023-06-30 | $1.7M | 36k | 47.03 |
| 2023-03-31 | $1.5M | 36k | 41.97 |
| 2022-12-31 | $1.4M | 36k | 38.13 |
| 2019-12-31 | $251k | 3.5k | 72.19 |
| 2019-09-30 | $324k | 2.3k | 140.32 |
| 2019-06-30 | $373k | 2.0k | 183.29 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors